Boiron S.A (BOI) | Financial Analysis & Statements
Boiron S.A. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
602.8M
Total Liabilities
210.0M
Shareholders Equity
392.8M
Debt to Equity
0.53
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Boiron S.A Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 501.1M | 487.6M | 493.2M | 534.2M | 455.2M |
| Cost of Goods Sold | 135.4M | 128.8M | 135.2M | 154.5M | 127.6M |
| Gross Profit | 365.7M | 358.8M | 358.1M | 379.7M | 327.6M |
| Gross Margin % | 73.0% | 73.6% | 72.6% | 71.1% | 72.0% |
| Operating Expenses | |||||
| Research & Development | 5.7M | 6.3M | 5.8M | 6.1M | 3.0M |
| Selling, General & Administrative | 244.5M | 238.3M | 232.8M | 236.9M | 212.8M |
| Other Operating Expenses | 79.3M | 78.4M | 79.3M | 80.1M | 73.1M |
| Total Operating Expenses | 329.4M | 322.9M | 317.9M | 323.1M | 288.9M |
| Operating Income | 36.4M | 35.8M | 40.8M | 56.6M | 39.5M |
| Operating Margin % | 7.3% | 7.3% | 8.3% | 10.6% | 8.7% |
| Non-Operating Items | |||||
| Interest Income | 2.5M | 2.9M | 7.5M | 1.8M | 590.0K |
| Interest Expense | 1.1M | 1.2M | 1.2M | 607.0K | 359.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 42.9M | 14.6M | 46.9M | 59.2M | 46.1M |
| Income Tax | 10.2M | 3.2M | 12.9M | 14.9M | 17.6M |
| Effective Tax Rate % | 23.8% | 22.2% | 27.6% | 25.2% | 38.1% |
| Net Income | 32.6M | 11.3M | 33.9M | 44.3M | 28.6M |
| Net Margin % | 6.5% | 2.3% | 6.9% | 8.3% | 6.3% |
| Key Metrics | |||||
| EBITDA | 51.7M | 79.9M | 65.3M | 70.0M | 59.5M |
| EPS (Basic) | €1.88 | €0.65 | €2.06 | €2.57 | €1.63 |
| EPS (Diluted) | €1.88 | €0.65 | €2.06 | €2.57 | €1.63 |
| Basic Shares Outstanding | 17362275 | 17362275 | 17362222 | 17389171 | 17516468 |
| Diluted Shares Outstanding | 17362275 | 17362275 | 17362222 | 17389171 | 17516468 |
Income Statement Trend
Boiron S.A Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 79.3M | 64.7M | 74.0M | 250.9M | 234.5M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 93.5M | 89.9M | 87.0M | 100.5M | 97.3M |
| Inventory | 98.6M | 101.1M | 96.8M | 96.9M | 85.6M |
| Other Current Assets | 650.0K | 425.0K | 419.0K | 26.3M | 29.8M |
| Total Current Assets | 293.5M | 281.0M | 286.2M | 477.8M | 452.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 188.2M | 186.3M | 182.6M | 28.7M | 194.7M |
| Goodwill | 209.5M | 208.8M | 209.5M | 219.9M | 210.3M |
| Intangible Assets | 30.3M | 29.3M | 30.1M | 31.9M | 31.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 61.0K | 52.0K | 86.0K | 39.0K | 41.0K |
| Total Non-Current Assets | 309.3M | 295.3M | 304.0M | 311.7M | 318.3M |
| Total Assets | 602.8M | 576.3M | 590.2M | 789.5M | 770.7M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 39.6M | 37.2M | 44.6M | 48.2M | 44.2M |
| Short-term Debt | 12.7M | 4.5M | 7.1M | 5.4M | 4.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.7M | 3.7M | 3.9M | 4.3M | - |
| Total Current Liabilities | 132.1M | 111.8M | 126.3M | 153.2M | 158.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 18.7M | 10.5M | 6.6M | 16.7M | 7.7M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | - |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 78.0M | 86.3M | 72.4M | 79.0M | 80.7M |
| Total Liabilities | 210.0M | 198.1M | 198.7M | 232.1M | 238.9M |
| Equity | |||||
| Common Stock | 17.5M | 17.5M | 17.5M | 17.5M | 17.5M |
| Retained Earnings | - | - | - | 460.2M | 434.3M |
| Treasury Stock | 7.4M | 7.4M | 7.4M | 7.0M | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 392.8M | 378.2M | 391.5M | 557.3M | 531.8M |
| Key Metrics | |||||
| Total Debt | 31.5M | 15.0M | 13.7M | 22.2M | 12.6M |
| Working Capital | 161.4M | 169.2M | 159.9M | 324.6M | 294.1M |
Balance Sheet Composition
Boiron S.A Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 32.6M | 11.3M | 35.8M | 44.7M | 28.6M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.5M | -1.2M | 7.7M | 6.9M | -23.0M |
| Operating Cash Flow | 28.7M | 8.5M | 24.9M | 40.0M | -3.0M |
| Investing Activities | |||||
| Capital Expenditures | -14.2M | -8.4M | -7.6M | -2.7M | -648.0K |
| Acquisitions | 0 | -977.0K | 0 | -1.7M | - |
| Investment Purchases | -1.4M | -2.2M | -7.2M | -3.0M | -1.9M |
| Investment Sales | 251.0K | 736.0K | 89.0K | 439.0K | 84.0K |
| Investing Cash Flow | -15.4M | -10.8M | -14.8M | -6.9M | -2.5M |
| Financing Activities | |||||
| Share Repurchases | -43.0K | -206.0K | -122.0K | -6.4M | -12.0K |
| Dividends Paid | -20.8M | -23.4M | -199.0M | -16.5M | -16.6M |
| Debt Issuance | 0 | 0 | 19.0K | 22.0K | 3.0K |
| Debt Repayment | 0 | -1.3M | -1.0M | -963.0K | -1.2M |
| Financing Cash Flow | -18.4M | -22.0M | -193.2M | -22.3M | -17.2M |
| Free Cash Flow | 29.7M | 23.6M | 27.5M | 40.1M | 12.9M |
| Net Change in Cash | -5.1M | -24.4M | -183.0M | 10.7M | -22.7M |
Cash Flow Trend
Boiron S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.15
Forward P/E
12.07
Price to Book
1.21
Price to Sales
0.88
PEG Ratio
12.07
Profitability Ratios
Profit Margin
3.84%
Operating Margin
8.94%
Return on Equity
5.22%
Return on Assets
6.20%
Financial Health
Current Ratio
2.39
Debt to Equity
4.90
Beta
0.25
Per Share Data
EPS (TTM)
€1.11
Book Value per Share
€21.26
Revenue per Share
€29.08
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BOI | 446.2M | 23.15 | 1.21 | 5.22% | 3.84% | 4.90 |
| Ipsen S.A | 13.4B | 30.83 | 3.12 | 10.44% | 11.29% | 22.38 |
| Euroapi S.A.S.U | 121.5M | 8.84 | 0.20 | -23.84% | -24.77% | 8.30 |
| AB Science S.A | 76.8M | -7.73 | - | 32.97% | 116.42% | -0.80 |
| CoreTech Limited | 1.3M | - | - | -102.42% | 137.36% | -1.03 |
Financial data is updated regularly. All figures are in the company's reporting currency.